SOX9 and neoplasm: This may be partly explained by the observation that estrogen reduces Sox9 expression in ER-positive cells, resulting in high Sox9 levels in ER-negative tumour cells and in tamoxifen-resistant cells, likely due to their reduced ER activity [12].